(+)-schisandrin B multiple interactions ISO RGD:620893 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA] CTD PMID:31150632 (S)-nicotine multiple interactions ISO RGD:730889 6480464 [[Nicotine promotes the reaction [Peroxynitrous Acid results in increased activity of PRKAA2 protein]] which results in increased phosphorylation of FASN protein] which results in decreased activity of FASN protein more ... CTD PMID:17635921 (S)-nicotine increases expression ISO RGD:620893 6480464 Nicotine results in increased expression of PRKAA2 mRNA CTD PMID:22265867 1,1-dichloroethene decreases expression ISO RGD:730889 6480464 vinylidene chloride results in decreased expression of PRKAA2 mRNA CTD PMID:26682919 17alpha-ethynylestradiol multiple interactions ISO RGD:730889 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:620893 6480464 Ethinyl Estradiol results in increased expression of PRKAA2 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:730889 6480464 Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] CTD PMID:16990341 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PRKAA2 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions ISO RGD:620893 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PRKAA2 mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:730889 6480464 Estradiol results in decreased expression of PRKAA2 mRNA CTD PMID:19484750 17beta-estradiol decreases expression ISO RGD:620893 6480464 Estradiol results in decreased expression of PRKAA2 mRNA CTD PMID:20068009 17beta-hydroxy-5alpha-androstan-3-one decreases phosphorylation ISO RGD:730889 6480464 Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein CTD PMID:16990341 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:730889 6480464 Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] CTD PMID:16990341 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:730889 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PRKAA2 gene] CTD PMID:17942748 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:730889 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKAA2 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:730889 6480464 Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620893 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKAA2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:620893 6480464 Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA CTD PMID:22298810 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:620893 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:620893 6480464 3 more ... CTD PMID:29474705 4,4'-diaminodiphenylmethane decreases expression ISO RGD:620893 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PRKAA2 mRNA CTD PMID:30723492 4-nonylphenol multiple interactions ISO RGD:620893 6480464 [4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA, [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of PRKAA2 mRNA CTD PMID:30228064 acrylamide decreases expression ISO RGD:620893 6480464 Acrylamide results in decreased expression of PRKAA2 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:730889 6480464 Aflatoxin B1 results in increased expression of PRKAA2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of PRKAA2 gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PRKAA2 mRNA CTD PMID:22100608 aflatoxin M1 decreases expression EXP 6480464 Aflatoxin M1 results in decreased expression of PRKAA2 mRNA CTD PMID:30928695 AICA ribonucleotide multiple interactions ISO RGD:730889 6480464 [AICA ribonucleotide results in increased activity of PRKAA2 protein] which results in decreased activity of FASN protein more ... CTD PMID:15806154 more ... AICA ribonucleotide multiple interactions ISO RGD:620893 6480464 PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] CTD PMID:22815988 AICA ribonucleotide increases phosphorylation EXP 6480464 AICA ribonucleotide results in increased phosphorylation of PRKAA2 protein CTD PMID:18482975 AICA ribonucleotide increases activity ISO RGD:730889 6480464 AICA ribonucleotide results in increased activity of PRKAA2 protein CTD PMID:17635921 AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA2 protein, PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA] CTD PMID:16873680 , PMID:21205922 aldehydo-D-glucose multiple interactions EXP 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 aldehydo-D-glucose decreases expression ISO RGD:620893 6480464 Glucose results in decreased expression of PRKAA2 mRNA, Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 aldehydo-D-glucose affects response to substance ISO RGD:620893 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 aldehydo-D-glucose multiple interactions ISO RGD:730889 6480464 Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein more ... CTD PMID:15806154 more ... amiodarone increases phosphorylation EXP 6480464 Amiodarone results in increased phosphorylation of PRKAA2 protein CTD PMID:23912912 ammonium chloride affects expression ISO RGD:620893 6480464 Ammonium Chloride affects the expression of PRKAA2 mRNA CTD PMID:16483693 benzalkonium chloride increases expression ISO RGD:730889 6480464 Benzalkonium Compounds results in increased expression of PRKAA2 mRNA CTD PMID:31199489 benzo[a]pyrene decreases expression ISO RGD:730889 6480464 Benzo(a)pyrene results in decreased expression of PRKAA2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:20018196 bisphenol A multiple interactions ISO RGD:620893 6480464 [4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA more ... CTD PMID:26496021 , PMID:30228064 bisphenol A decreases expression ISO RGD:620893 6480464 bisphenol A results in decreased expression of PRKAA2 mRNA CTD PMID:27539358 bisphenol A increases methylation ISO RGD:730889 6480464 bisphenol A results in increased methylation of PRKAA2 promoter CTD PMID:27312807 bisphenol A increases methylation ISO RGD:620893 6480464 bisphenol A results in increased methylation of PRKAA2 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:620893 6480464 bisphenol A results in increased expression of PRKAA2 mRNA CTD PMID:25181051 , PMID:29097150 butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of PRKAA2 mRNA CTD PMID:26079696 cadmium sulfate multiple interactions ISO RGD:730889 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PRKAA2 mRNA] CTD PMID:16221973 caffeine increases expression ISO RGD:620893 6480464 Caffeine results in increased expression of PRKAA2 mRNA CTD PMID:22583948 carbon nanotube decreases expression ISO RGD:730889 6480464 Nanotubes, Carbon analog results in decreased expression of PRKAA2 mRNA, Nanotubes, Carbon results in decreased expression of PRKAA2 mRNA CTD PMID:25554681 carmustine affects response to substance EXP 6480464 PRKAA2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PRKAA2 mRNA CTD PMID:27392435 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PRKAA2 mRNA CTD PMID:27392435 copper atom decreases expression ISO RGD:620893 6480464 Copper results in decreased expression of PRKAA2 mRNA CTD PMID:22465980 copper(0) decreases expression ISO RGD:620893 6480464 Copper results in decreased expression of PRKAA2 mRNA CTD PMID:22465980 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of PRKAA2 mRNA CTD PMID:19549813 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PRKAA2 mRNA CTD PMID:27989131 cyproconazole increases expression ISO RGD:730889 6480464 cyproconazole results in increased expression of PRKAA2 mRNA CTD PMID:22045034 D-glucose multiple interactions ISO RGD:730889 6480464 Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein more ... CTD PMID:15806154 more ... D-glucose decreases expression ISO RGD:620893 6480464 Glucose results in decreased expression of PRKAA2 mRNA, Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 D-glucose multiple interactions EXP 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 D-glucose affects response to substance ISO RGD:620893 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 DDT decreases expression ISO RGD:620893 6480464 DDT results in decreased expression of PRKAA2 mRNA CTD PMID:30207508 dibutyl phthalate increases expression ISO RGD:730889 6480464 Dibutyl Phthalate results in increased expression of PRKAA2 mRNA CTD PMID:21266533 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of PRKAA2 mRNA CTD PMID:24236059 dioxygen multiple interactions ISO RGD:620893 6480464 PRKAA2 mutant form inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA] CTD PMID:22892143 dioxygen increases expression ISO RGD:620893 6480464 Oxygen results in increased expression of PRKAA2 mRNA CTD PMID:22911455 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:19625624 , PMID:27188386 doxorubicin decreases expression ISO RGD:620893 6480464 Doxorubicin results in decreased expression of PRKAA2 mRNA CTD PMID:26721193 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PRKAA2 mRNA CTD PMID:29803840 econazole multiple interactions ISO RGD:730889 6480464 [tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein CTD PMID:30698772 endosulfan affects expression ISO RGD:620893 6480464 Endosulfan affects the expression of PRKAA2 mRNA CTD PMID:29391264 entinostat increases expression EXP 6480464 entinostat results in increased expression of PRKAA2 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:730889 6480464 [Ethanol co-treated with PRKAA2 protein] affects the expression of PRKAA1 protein more ... CTD PMID:23448468 flutamide decreases expression ISO RGD:620893 6480464 Flutamide results in decreased expression of PRKAA2 mRNA CTD PMID:24136188 glafenine decreases expression ISO RGD:620893 6480464 Glafenine results in decreased expression of PRKAA2 mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:730889 6480464 Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein more ... CTD PMID:15806154 more ... glucose decreases expression ISO RGD:620893 6480464 Glucose results in decreased expression of PRKAA2 mRNA, Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 glucose multiple interactions EXP 6480464 [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 glucose affects response to substance ISO RGD:620893 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 hexaconazole increases expression ISO RGD:730889 6480464 hexaconazole results in increased expression of PRKAA2 mRNA CTD PMID:22045034 hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of PRKAA2 mRNA CTD PMID:30547786 histamine multiple interactions EXP 6480464 [PRKAA1 protein co-treated with PRKAA2 protein] affects the reaction [Histamine results in increased phosphorylation of NOS2 protein] CTD PMID:21145922 mercury dichloride decreases expression ISO RGD:730889 6480464 Mercuric Chloride results in decreased expression of PRKAA2 mRNA CTD PMID:22019852 metformin multiple interactions EXP 6480464 Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:16873680 metformin increases phosphorylation ISO RGD:620893 6480464 Metformin results in increased phosphorylation of PRKAA2 protein CTD PMID:19594306 metformin increases activity ISO RGD:620893 6480464 Metformin results in increased activity of PRKAA2 protein CTD PMID:18484962 metformin affects response to substance ISO RGD:730889 6480464 PRKAA2 protein affects the susceptibility to Metformin CTD PMID:20847317 metformin multiple interactions ISO RGD:620893 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein], Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:21186350 metformin increases activity ISO RGD:730889 6480464 Metformin results in increased activity of PRKAA2 protein CTD PMID:17635921 metformin multiple interactions ISO RGD:730889 6480464 [Metformin results in increased activity of PRKAA2 protein] which results in decreased activity of FASN protein more ... CTD PMID:17635921 more ... methapyrilene decreases expression ISO RGD:620893 6480464 Methapyrilene results in decreased expression of PRKAA2 mRNA CTD PMID:30467583 methotrexate multiple interactions EXP 6480464 PRKAA2 mutant form inhibits the reaction [Methotrexate results in increased expression of HMOX1 mRNA] more ... CTD PMID:25575725 N-acetyl-L-cysteine multiple interactions ISO RGD:730889 6480464 Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of PRKAA2 protein] CTD PMID:17635921 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of PRKAA2 mRNA CTD PMID:24768652 , PMID:25583101 nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [6 more ... CTD PMID:18482975 nicotine increases expression ISO RGD:620893 6480464 Nicotine results in increased expression of PRKAA2 mRNA CTD PMID:22265867 nicotine multiple interactions ISO RGD:730889 6480464 [[Nicotine promotes the reaction [Peroxynitrous Acid results in increased activity of PRKAA2 protein]] which results in increased phosphorylation of FASN protein] which results in decreased activity of FASN protein more ... CTD PMID:17635921 nicotinic acid increases activity EXP 6480464 Niacin results in increased activity of PRKAA2 protein CTD PMID:14749208 nitrites multiple interactions ISO RGD:620893 6480464 PRKAA2 mutant form inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA] CTD PMID:22892143 nitrofen decreases expression ISO RGD:620893 6480464 nitrofen results in decreased expression of PRKAA2 mRNA CTD PMID:26720608 oleic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of PRKAA2 mRNA CTD PMID:30547786 paracetamol affects expression ISO RGD:730889 6480464 Acetaminophen affects the expression of PRKAA2 mRNA CTD PMID:17562736 paraquat affects response to substance ISO RGD:730889 6480464 PRKAA2 gene affects the susceptibility to Paraquat CTD PMID:25092649 paraquat increases expression ISO RGD:730889 6480464 Paraquat results in increased expression of PRKAA2 protein CTD PMID:27324791 paraquat increases phosphorylation ISO RGD:730889 6480464 Paraquat results in increased phosphorylation of PRKAA2 protein CTD PMID:25092649 peroxynitrous acid multiple interactions ISO RGD:730889 6480464 [[Nicotine promotes the reaction [Peroxynitrous Acid results in increased activity of PRKAA2 protein]] which results in increased phosphorylation of FASN protein] which results in decreased activity of FASN protein more ... CTD PMID:17635921 phenobarbital decreases expression ISO RGD:730889 6480464 Phenobarbital results in decreased expression of PRKAA2 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of PRKAA2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKAA2 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:730889 6480464 pirinixic acid results in increased expression of PRKAA2 mRNA CTD PMID:18301758 pirinixic acid increases expression ISO RGD:620893 6480464 pirinixic acid results in increased expression of PRKAA2 mRNA CTD PMID:19236843 platycodin D multiple interactions ISO RGD:730889 6480464 platycodin D results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:30599906 potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of PRKAA2 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:730889 6480464 Pregnenolone Carbonitrile results in decreased expression of PRKAA2 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:620893 6480464 Progesterone results in increased expression of PRKAA2 mRNA CTD PMID:20726854 reactive oxygen species affects abundance EXP 6480464 PRKAA2 protein affects the abundance of Reactive Oxygen Species CTD PMID:21145922 reactive oxygen species multiple interactions ISO RGD:730889 6480464 Reactive Oxygen Species affects the reaction [Nicotine results in increased phosphorylation of PRKAA2 protein] CTD PMID:17635921 resveratrol multiple interactions EXP 6480464 [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:16873680 more ... resveratrol affects response to substance ISO RGD:730889 6480464 PRKAA2 protein affects the susceptibility to resveratrol CTD PMID:23090186 resveratrol increases phosphorylation EXP 6480464 resveratrol results in increased phosphorylation of PRKAA2 protein CTD PMID:18482975 , PMID:20080969 resveratrol decreases expression ISO RGD:730889 6480464 resveratrol results in decreased expression of PRKAA2 mRNA CTD PMID:22610192 resveratrol decreases activity ISO RGD:730889 6480464 resveratrol results in decreased activity of PRKAA2 protein CTD PMID:19934007 resveratrol increases phosphorylation ISO RGD:730889 6480464 resveratrol results in increased phosphorylation of PRKAA2 protein CTD PMID:17438283 resveratrol multiple interactions ISO RGD:730889 6480464 PRKAA2 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] more ... CTD PMID:17438283 more ... SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate increases expression ISO RGD:730889 6480464 sodium arsenate results in increased expression of PRKAA2 mRNA CTD PMID:21795629 succimer multiple interactions ISO RGD:730889 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKAA2 mRNA CTD PMID:26378955 sucrose multiple interactions ISO RGD:620893 6480464 [Dietary Fats co-treated with Sucrose] results in decreased expression of PRKAA2 mRNA, Biological Products inhibits the reaction [[Dietary Fats co-treated with Sucrose] results in decreased expression of PRKAA2 mRNA] CTD PMID:31175915 sulindac multiple interactions ISO RGD:620893 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKAA2 mRNA CTD PMID:20371263 tebuconazole multiple interactions ISO RGD:730889 6480464 [tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein CTD PMID:30698772 temozolomide affects response to substance EXP 6480464 PRKAA2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of PRKAA2 mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO RGD:620893 6480464 Carbon Tetrachloride affects the expression of PRKAA2 mRNA CTD PMID:12734012 tetrachloromethane multiple interactions ISO RGD:620893 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:620893 6480464 Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA CTD PMID:16239168 , PMID:31150632 tetrachloromethane affects expression ISO RGD:730889 6480464 Carbon Tetrachloride affects the expression of PRKAA2 mRNA CTD PMID:17484886 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of PRKAA2 mRNA CTD PMID:24935251 Triptolide increases expression ISO RGD:620893 6480464 triptolide results in increased expression of PRKAA2 mRNA CTD PMID:23639586 valproic acid increases expression ISO RGD:730889 6480464 Valproic Acid results in increased expression of PRKAA2 mRNA CTD PMID:22045034 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PRKAA2 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKAA2 mRNA CTD PMID:27188386 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PRKAA2 mRNA CTD PMID:25979313 vancomycin increases expression ISO RGD:730889 6480464 Vancomycin results in increased expression of PRKAA2 mRNA CTD PMID:18930951 vinclozolin increases expression ISO RGD:620893 6480464 vinclozolin results in increased expression of PRKAA2 mRNA CTD PMID:23555832 vinclozolin affects expression ISO RGD:620893 6480464 vinclozolin affects the expression of PRKAA2 mRNA CTD PMID:19015723 vinclozolin decreases expression ISO RGD:620893 6480464 vinclozolin results in decreased expression of PRKAA2 mRNA CTD PMID:23034163 zearalenone increases expression ISO RGD:730889 6480464 Zearalenone results in increased expression of PRKAA2 mRNA CTD PMID:30717214